Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 6990-6998

  Bruscia, Emanuela M ^a   Zhang, Ping Xia ^a   Satoh, Ayano ^b   Caputo, Christina ^a   Medzhitov, Ruslan ^a   Shenoy, Ambika ^a   Egan, Marie E ^a   Krause, Diane S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; CELL MIGRATION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; LYSOSOME; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ANIMALS; CYSTIC FIBROSIS; HUMANS; INFLAMMATION; MICE; PROTEIN TRANSPORT; TOLL-LIKE RECEPTOR 4;

EID: 79959572825     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100396     Document Type: Article

References (50)

1. Yoshimura, K., H. Nakamura, B. C. Trapnell, C. S. Chu, W. Dalemans, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1991. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res. 19: 5417-5423.
2. Chmiel, J. F., and P. B. Davis. 2003. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir. Res. 4: 8.
3. Hubeau, C., E. Puchelle, and D. Gaillard. 2001. Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis. J. Allergy Clin. Immunol. 108: 524-529.
4. Armstrong, D. S., K. Grimwood, R. Carzino, J. B. Carlin, A. Olinsky, and P. D. Phelan. 1995. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 310: 1571-1572.
5. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151: 1075-1082.
6. Brennan, S., G. L. Hall, F. Horak, A. Moeller, P. M. Pitrez, A. Franzmann, S. Turner, N. de Klerk, P. Franklin, K. R. Winfield, et al. 2005. Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation. Thorax 60: 159-163. (Pubitemid 40222900)
7. Brennan, S., P. D. Sly, C. L. Gangell, N. Sturges, K. Winfield, M. Wikstrom, S. Gard, and J. W. Upham. 2009. Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Eur. Respir. J. 34: 655-661.
8. Zaman, M. M., A. Gelrud, O. Junaidi, M. M. Regan, M. Warny, J. C. Shea, C. Kelly, B. P. O'Sullivan, and S. D. Freedman. 2004. Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin. Diagn. Lab. Immunol. 11: 819-824.
9. Di, A., M. E. Brown, L. V. Deriy, C. Li, F. L. Szeto, Y. Chen, P. Huang, J. Tong, A. P. Naren, V. Bindokas, et al. 2006. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat. Cell Biol. 8: 933-944.
10. Andersson, C., M. M. Zaman, A. B. Jones, and S. D. Freedman. 2008. Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophages. J. Cyst. Fibros. 7: 68-78.
11. -/- mice. Am. J. Respir. Cell Mol. Biol. 40: 295-304.
12. Xu, Y., A. Krause, H. Hamai, B. G. Harvey, T. S. Worgall, and S. Worgall. 2010. Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA. PLoS ONE 5: e11004.
13. Morris, M. R., I. J. Doull, S. Dewitt, and M. B. Hallett. 2005. Reduced iC3b-mediated phagocytotic capacity of pulmonary neutrophils in cystic fibrosis. Clin. Exp. Immunol. 142: 68-75.
14. Painter, R. G., V. G. Valentine, N. A. Lanson, Jr., K. Leidal, Q. Zhang, G. Lombard, C. Thompson, A. Viswanathan, W. M. Nauseef, G. Wang, and G. Wang. 2006. CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45: 10260-10269. (Pubitemid 44384801)
15. Xu, Y., C. Tertilt, A. Krause, L. E. Quadri, R. G. Crystal, and S. Worgall. 2009. Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells. Respir. Res. 10: 26.
16. Moss, R. B., Y. P. Hsu, and L. Olds. 2000. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin. Exp. Immunol. 120: 518-525.
17. Hubeau, C., R. Le Naour, M. Abély, J. Hinnrasky, M. Guenounou, D. Gaillard, and E. Puchelle. 2004. Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin. Exp. Immunol. 135: 528-534.
18. Mueller, C., S. A. Braag, A. Keeler, C. Hodges, M. Drumm, and T. R. Flotte. 2010. Lack of Cftr in CD3+ lymphocytes leads to aberrant cytokine secretion and hyper-inflammatory adaptive immune responses. Am. J. Respir. Cell Mol. Biol. DOI: 10.1165/rcmb.2010-0224OC.
19. Zhang, Y., X. Li, H. Grassmé, G. Döring, and E. Gulbins. 2010. Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection. J. Immunol. 184: 5104-5111.
20. Bihl, F., L. Salez, M. Beaubier, D. Torres, L. Larivière, L. Laroche, A. Benedetto, D. Martel, J. M. Lapointe, B. Ryffel, and D. Malo. 2003. Overexpression of Toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice. J. Immunol. 170: 6141-6150. (Pubitemid 36682597)
21. Wang, Y., T. Chen, C. Han, D. He, H. Liu, H. An, Z. Cai, and X. Cao. 2007. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4. Blood 110: 962-971. (Pubitemid 47267435)
22. Muzio, M., N. Polntarutti, D. Bosisio, M. K. Prahladan, and A. Mantovani. 2000. Toll like receptor family (TLT) and signalling pathway. Eur. Cytokine Netw. 11: 489-490.
23. Visintin, A., A. Mazzoni, J. H. Spitzer, D. H. Wyllie, S. K. Dower, and D. M. Segal. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166: 249-255.
24. Vij, N., S. Mazur, and P. L. Zeitlin. 2009. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE 4: e4664.
25. Kagan, J. C., T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat. Immunol. 9: 361-368.
26. Basiji, D. A., W. E. Ortyn, L. Liang, V. Venkatachalam, and P. Morrissey. 2007. Cellular image analysis and imaging by flow cytometry. Clin. Lab. Med. 27: 653-670, viii.
27. Husebye, H., O. Halaas, H. Stenmark, G. Tunheim, O. Sandanger, B. Bogen, A. Brech, E. Latz, and T. Espevik. 2006. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 25: 683-692. (Pubitemid 43292431)
28. Press, B., Y. Feng, B. Hoflack, and A. Wandinger-Ness. 1998. Mutant Rab7 causes the accumulation of cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment. J. Cell Biol. 140: 1075-1089. (Pubitemid 28128868)
29. Bucci, C., P. Thomsen, P. Nicoziani, J. McCarthy, and B. van Deurs. 2000. Rab7: a key to lysosome biogenesis. Mol. Biol. Cell 11: 467-480.
30. Sonawane, N. D., and A. S. Verkman. 2008. Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis. Bioorg. Med. Chem. 16: 8187-8195.
31. Perez, A., A. C. Issler, C. U. Cotton, T. J. Kelley, A. S. Verkman, and P. B. Davis. 2007. CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L383-L395.
32. McGettrick, A. F., and L. A. O'Neill. 2010. Localisation and trafficking of Tolllike receptors: an important mode of regulation. Curr. Opin. Immunol. 22: 20-27.
33. Latz, E., A. Visintin, E. Lien, K. A. Fitzgerald, B. G. Monks, E. A. Kurt-Jones, D. T. Golenbock, and T. Espevik. 2002. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277: 47834-47843.
34. Jiang, Q., S. Akashi, K. Miyake, and H. R. Petty. 2000. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J. Immunol. 165: 3541-3544.
35. Triantafilou, M., K. Miyake, D. T. Golenbock, and K. Triantafilou. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115: 2603-2611. (Pubitemid 34778077)
36. Gruenberg, J., and H. Stenmark. 2004. The biogenesis of multivesicular endosomes. Nat. Rev. Mol. Cell Biol. 5: 317-323.
37. Saitoh, S. I. 2009. Chaperones and transport proteins regulate TLR4 trafficking and activation. Immunobiology 214: 594-600.
38. Palsson-McDermott, E. M., S. L. Doyle, A. F. McGettrick, M. Hardy, H. Husebye, K. Banahan, M. Gong, D. Golenbock, T. Espevik, and L. A. O'Neill. 2009. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat. Immunol. 10: 579-586.
39. John, G., A. O. Yildirim, B. K. Rubin, D. C. Gruenert, and M. O. Henke. 2010. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. Am. J. Respir. Cell Mol. Biol. 42: 424-431.
40. Muir, A., G. Soong, S. Sokol, B. Reddy, M. I. Gomez, A. Van Heeckeren, and A. Prince. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30: 777-783.
41. Kobayashi, M., S. Saitoh, N. Tanimura, K. Takahashi, K. Kawasaki, M. Nishijima, Y. Fujimoto, K. Fukase, S. Akashi-Takamura, and K. Miyake. 2006. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 176: 6211-6218.
42. Haggie, P. M., and A. S. Verkman. 2009. Defective organellar acidification as a cause of cystic fibrosis lung disease: reexamination of a recurring hypothesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L859-L867.
43. Teichgräber, V., M. Ulrich, N. Endlich, J. Riethmüller, B. Wilker, C. C. De Oliveira-Munding, A. M. van Heeckeren, M. L. Barr, G. von Kürthy, K. W. Schmid, et al. 2008. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med. 14: 382-391.
44. Deriy, L. V., E. A. Gomez, G. Zhang, D. W. Beacham, J. A. Hopson, A. J. Gallan, P. D. Shevchenko, V. P. Bindokas, and D. J. Nelson. 2009. Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages. J. Biol. Chem. 284: 35926-35938.
45. Haggie, P. M., and A. S. Verkman. 2007. Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages. J. Biol. Chem. 282: 31422-31428.
46. Haggie, P. M., and A. S. Verkman. 2009. Unimpaired lysosomal acidification in respiratory epithelial cells in cystic fibrosis. J. Biol. Chem. 284: 7681-7686.
47. Barriere, H., M. Bagdany, F. Bossard, T. Okiyoneda, G. Wojewodka, D. Gruenert, D. Radzioch, and G. L. Lukacs. 2009. Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles. Mol. Biol. Cell 20: 3125-3141.
48. Gentzsch, M., A. Choudhury, X. B. Chang, R. E. Pagano, and J. R. Riordan. 2007. Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. J. Cell Sci. 120: 447-455.
49. Suzuki, M., Y. Sugimoto, Y. Ohsaki, M. Ueno, S. Kato, Y. Kitamura, H. Hosokawa, J. P. Davies, Y. A. Ioannou, M. T. Vanier, et al. 2007. Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain. J. Neurosci. 27: 1879-1891.
50. Sturges, N. C., M. E. Wikström, K. R. Winfield, S. E. Gard, S. Brennan, P. D. Sly, J.W. Upham; AREST CF Members of the Australian Respiratory Early Surveillance Team for Cystic Fibrosis. 2010. Monocytes from children with clinically stable cystic fibrosis show enhanced expression of Toll-like receptor 4. Pediatr. Pulmonol. 45: 883-889.